It was in January that Haas announced that its founder and talismanic boss Guenther Steiner was leaving. In essence the Italian was no longer on the same page as owner Gene Haas with regard to how to ...

Thousands of people in the U.S. are waiting for organ transplants but there are not enough donors. One solution to the shortage may be found in pigs. A Georgia grandmother is now the fifth person ...

The 53-year-old from Alabama has now become the latest recipient of a gene-edited pig kidney -- and is currently the only living person with an animal organ transplant -- a New York hospital ...

As Stewart-Haas Racing (SHR) winds down operations, Gene Haas is already charting the path forward. With Brad Keselowski and RFK Racing by his side, Haas Factory Team is poised to carry on SHR’s ...

In a recent study published in the journal Nature Biotechnology, researchers explored the potential of artificial intelligence (AI) techniques to improve gene therapy delivery systems specifically for ...

"It's a total movement, and it's very recognisable," said Simon Haas. "In the last 10 years, the trajectory at Design Miami is clear – and that defines a movement." "I see the work at Design ...

Sandisk Corporation, the maker of flash drives and memory cards, debuted a new logo today, and it’s based on a single pixel. “It all started with the pixel, which is the fundamental smallest ...

Earlier this month, I teased an upcoming interview with Rene Haas, CEO of chip design company Arm. I sat down live in Silicon Valley with Rene at an event hosted by AlixPartners, the full version ...

Job advertisement The University of Veterinary Medicine Hannover (TiHo) is inviting applications for a W3 Professorship in "Buiatrics" (m/f/d), whi... We are looking for an excellent young ...

As WWE prepares for Monday Night Raw's move to Netflix on Jan. 6, Chief Content Officer Paul "Triple H" Levesque revealed the new logo for the company's flagship show in a hype video on social media.

In a new study, scientists combined strategies to deliver energy-disrupting gene therapy using nanoparticles manufactured to zero in only on cancer cells. Experiments showed the targeted therapy ...